Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ColActive Transfer
- Development stage
- Unknown
- Lead developer
- Covalon Technologies
- Administration
- Topical
01
Overview
ColActive Transfer is a medical device wound dressing developed by Covalon Technologies. It is a porous wound contact layer composed of collagen and sodium alginate, provided as a sterile sheet. The dressing is indicated for the management of full- and partial-thickness wounds, including pressure injuries, diabetic ulcers, venous ulcers, second-degree burns, donor and graft sites, abrasions, dehisced surgical wounds, and traumatic wounds healing by secondary intention. As a medical device, it functions as a low-adherent contact layer to minimize wound trauma during dressing changes and provides a moist environment to support the healing process.
- Brand names
- ColActive Transfer
Beyond the preview
Go deeper on ColActive Transfer.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ColActive Transfer.